
MicroTransponder Secures $65 Million to Enhance Vivistim Adoption for Chronic Stroke Recovery
RefleXion Medical, a theranostic oncology company, today announced the scheduled installation of its RefleXion® X1 platform with SCINTIX® biology-guided radiotherapy at Beverly Hills Cancer Center (BHCC), the first freestanding cancer center (FSCC)…